Eligibility Male Breast Cancer NCT01463072

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
locally advanced or metastatic breast cancer
Descrizione

metastatic breast cancer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278488
any estrogen receptor (er), progesterone receptor (pr), or human epidermal growth factor receptor 2 (her2neu) status as long as the patient will receive nab-paclitaxel alone
Descrizione

estrogen receptor; progesterone receptor ; human epidermal growth factor receptor 2

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0034804
UMLS CUI [2]
C0034833
UMLS CUI [3]
C3496586
first or second line chemotherapy treatment for metastatic disease
Descrizione

chemotherapy metastatic disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0027627
karnofsky performance scale (kps) >= 70%
Descrizione

karnofsky performance scale

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0206065
resolution of grade >= 2 toxicity from prior therapy (other than alopecia)
Descrizione

toxicity alopecia

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013221
UMLS CUI [1,2]
C0002170
peripheral neuropathy =< grade 1
Descrizione

peripheral neuropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0031117
absolute neutrophil count >= 1,500/mm^3
Descrizione

absolute neutrophil count

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0948762
platelets >= 100,000 cells/mm^3
Descrizione

platelets

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005821
hemoglobin (hb) >= 9.0 g/dl
Descrizione

hemoglobin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0518015
aspartate aminotransferase (ast) and alanine aminotransferase (alt) =< 2.5 x institutional upper limit of normal
Descrizione

Aspartate aminotransferase/Alanine aminotransferase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0805162
alkaline phosphatase =< 2.5 x upper limit of normal unless bone metastasis are present in the absence of liver metastases
Descrizione

alkaline phosphatase

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0201850
bilirubin =< 1.5 mg/dl
Descrizione

bilirubin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005437
creatinine clearance (calculated or 24 hour) >= 30 ml/min
Descrizione

creatinine clearance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0373595
ability to understand and the willingness to sign a written informed consent document
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients may not be receiving any other investigational agents
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
untreated central nervous system (cns) metastases or symptomatic cns metastases requiring escalating doses of corticosteroids
Descrizione

CNS metastases; dosage corticosteroids

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0001617
known history of allergic reactions to paclitaxel
Descrizione

hypersensitivity paclitaxel

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0144576
presence of any serious or uncontrolled infection
Descrizione

infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
receipt of a taxane for adjuvant therapy or metastatic disease in the last 12 months
Descrizione

adjuvant therapy taxane

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0677850
UMLS CUI [1,2]
C0215136

Similar models

Eligibility Male Breast Cancer NCT01463072

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
metastatic breast cancer
Item
locally advanced or metastatic breast cancer
boolean
C0278488 (UMLS CUI [1])
estrogen receptor; progesterone receptor ; human epidermal growth factor receptor 2
Item
any estrogen receptor (er), progesterone receptor (pr), or human epidermal growth factor receptor 2 (her2neu) status as long as the patient will receive nab-paclitaxel alone
boolean
C0034804 (UMLS CUI [1])
C0034833 (UMLS CUI [2])
C3496586 (UMLS CUI [3])
chemotherapy metastatic disease
Item
first or second line chemotherapy treatment for metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
karnofsky performance scale
Item
karnofsky performance scale (kps) >= 70%
boolean
C0206065 (UMLS CUI [1])
toxicity alopecia
Item
resolution of grade >= 2 toxicity from prior therapy (other than alopecia)
boolean
C0013221 (UMLS CUI [1,1])
C0002170 (UMLS CUI [1,2])
peripheral neuropathy
Item
peripheral neuropathy =< grade 1
boolean
C0031117 (UMLS CUI [1])
absolute neutrophil count
Item
absolute neutrophil count >= 1,500/mm^3
boolean
C0948762 (UMLS CUI [1])
platelets
Item
platelets >= 100,000 cells/mm^3
boolean
C0005821 (UMLS CUI [1])
hemoglobin
Item
hemoglobin (hb) >= 9.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Aspartate aminotransferase/Alanine aminotransferase
Item
aspartate aminotransferase (ast) and alanine aminotransferase (alt) =< 2.5 x institutional upper limit of normal
boolean
C0805162 (UMLS CUI [1])
alkaline phosphatase
Item
alkaline phosphatase =< 2.5 x upper limit of normal unless bone metastasis are present in the absence of liver metastases
boolean
C0201850 (UMLS CUI [1])
bilirubin
Item
bilirubin =< 1.5 mg/dl
boolean
C0005437 (UMLS CUI [1])
creatinine clearance
Item
creatinine clearance (calculated or 24 hour) >= 30 ml/min
boolean
C0373595 (UMLS CUI [1])
informed consent
Item
ability to understand and the willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
patients may not be receiving any other investigational agents
boolean
C2348568 (UMLS CUI [1])
CNS metastases; dosage corticosteroids
Item
untreated central nervous system (cns) metastases or symptomatic cns metastases requiring escalating doses of corticosteroids
boolean
C0686377 (UMLS CUI [1])
C0178602 (UMLS CUI [2,1])
C0001617 (UMLS CUI [2,2])
hypersensitivity paclitaxel
Item
known history of allergic reactions to paclitaxel
boolean
C0020517 (UMLS CUI [1,1])
C0144576 (UMLS CUI [1,2])
infection
Item
presence of any serious or uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
adjuvant therapy taxane
Item
receipt of a taxane for adjuvant therapy or metastatic disease in the last 12 months
boolean
C0677850 (UMLS CUI [1,1])
C0215136 (UMLS CUI [1,2])